{"name":"Sirion Therapeutics, Inc.","slug":"sirion-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Difluprednate Ophthalmic Emulsion","genericName":"Difluprednate Ophthalmic Emulsion","slug":"difluprednate-ophthalmic-emulsion","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Difluprednate Ophthalmic Emulsion","genericName":"Difluprednate Ophthalmic Emulsion","slug":"difluprednate-ophthalmic-emulsion","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOTHNDR2RoWGUwU3lJeHRocVBKaW5WQ09zM2xwWEQzS1JTMndGcFhUcDV0OUpsNTBycEgwVUY3YUJjZ01EOEJJOXdzaER6RF9yQncwc2txQmlGUnktdXBzNXFWVFhpREthbmlabF9vd0JCYTdyYkJnTUxaNkFsbl9tOGt0Qko4TWRmbjh0QnhQa1AtVkRESktTR2lR?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market - openPR.com","headline":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-02","type":"pipeline","source":"EIN News","summary":"Who’s Ahead in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market? Competitive Insights for 2026 - EIN News","headline":"Who’s Ahead in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market? Competitive Insights for 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNT284SHpFOFd3dEdNSmpHLXlpUVBKUzZPRkJmY2M4UFBCMWlkSG9rdWN6SjJFSlRRcVROZUtKUE5xcUtlYmFPSlVZOVhVOGh2TkhNUUNpSW54b19DRl9NZ2dUWkFNazI2Zzd3WmpPNklKb1RuaFY5ZWhqNVprMVoxSzdDcGVYbVJfaDFReGxwMVdQdG94SmRrODhqMnpQeUtyd3ZOTkNlNEhja1U1?oc=5","date":"2026-03-31","type":"pipeline","source":"Weekly Voice","summary":"Biotech Expansion Accelerating Viral Vector Manufacturing Market Insights 2026–2035 - Weekly Voice","headline":"Biotech Expansion Accelerating Viral Vector Manufacturing Market Insights 2026–2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE13RlQwaWg5b00wamZzRkR5UEdwZG9kcFNZQ01MU1RyM3p0cm15Mmtoc0MxdW83R1FxSjRIVk1WcFRPcjlHV3lFWFJVakZraExEODlRSWlRR3RRendIZTY3N1RGLUx2aFhL?oc=5","date":"2025-04-01","type":"pipeline","source":"Market.us","summary":"Conjunctivitis Treatment Market Growth Analysis | CAGR of 5.1% - Market.us","headline":"Conjunctivitis Treatment Market Growth Analysis | CAGR of 5.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOVjlSZ29ZTFlReHRaYzhGLXRneUVXQ3RtZ1ZpeC10VkQ5aTAyamN4SFFES0FuTjJwVzFUeXdpTjFULW11UmNabjVYanBLcGo3bzhSdExxNnFxMk13YzFFSERMdk9Zc0RlT2JKYmN5NXlMeVc1RzFUZEkwY0R6bWhDbXNtY2hPOFVDTXd6ajJLbWdMNDZsbC11WkRaNA?oc=5","date":"2024-07-18","type":"pipeline","source":"Allied Market Research","summary":"Viral Vectors and Plasmid DNA Manufacturing Market Forecast - 2033 - Allied Market Research","headline":"Viral Vectors and Plasmid DNA Manufacturing Market Forecast - 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMUhoSG9fMXRQUWxWbFNxNGsySm9BWVNhWHJXRXJEdXhLd1RyWF9qdGlsOWpQNERTWmxoaTc4UWNwa0t5b056Ymxxem9Sc3EwRzhXYTlkU2pmclJBUTFNSkxjR1hIUDRKWXZ4TUNNX0FVVjJTNWd3Q0tXLVF4dTJDVFBpcjlWUXVGdG00RXR6NlMxRnBRbDVOalB1TU4xN2NWNjBCZlh0NHc5dTA3UEhZWmhXZzlNcTAyTVFB?oc=5","date":"2022-07-05","type":"deal","source":"Fierce Biotech","summary":"Japan's Mitsubishi Tanabe and EditForce sign $146M deal to discover CNS gene therapies - Fierce Biotech","headline":"Japan's Mitsubishi Tanabe and EditForce sign $146M deal to discover CNS gene therapies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}